Want to join the conversation?
$APH narrowed its 2016 sales guidance to $6.08-6.20Bil from prior forecast of $6.04-6.20Bil. $APH also narrowed its 2016 EPS excluding one-time items outlook to $2.56-2.62 from previous estimate of $2.54-2.62. The latest sales guidance represents an increase of 9-11% over 2015 and EPS forecast represents a rise of 5-8% over 2015.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)